We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,672 results
  1. Optimal Control and Cost-Effectiveness Analysis of an HPV–Chlamydia trachomatis Co-infection Model

    In this work, a co-infection model for human papillomavirus (HPV) and Chlamydia trachomatis with cost-effectiveness optimal control analysis is...

    A. Omame, C. U. Nnanna, S. C. Inyama in Acta Biotheoretica
    Article 03 January 2021
  2. Infection control measures in times of antimicrobial resistance: a matter of solidarity

    Control measures directed at carriers of multidrug-resistant organisms are traditionally approached as a trade-off between public interests on the...

    Babette Rump, Aura Timen, ... Marcel Verweij in Monash Bioethics Review
    Article Open access 07 November 2020
  3. Raising concerns on questionable ethics approvals – a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection

    Background

    The practice of clinical research is strictly regulated by law. During submission and review processes, compliance of such research with...

    Fabrice Frank, Nans Florens, ... Lonni Besançon in Research Integrity and Peer Review
    Article Open access 03 August 2023
  4. Ethical considerations for HIV remission clinical research involving participants diagnosed during acute HIV infection

    HIV remission clinical researchers are increasingly seeking study participants who are diagnosed and treated during acute HIV infection—the brief...

    Adam Gilbertson, Joseph D. Tucker, ... Stuart Rennie in BMC Medical Ethics
    Article Open access 28 December 2021
  5. Infection control for third-party benefit: lessons from criminal justice

    This article considers what can be learned regarding the ethical acceptability of intrusive interventions intended to halt the spread of infectious...

    Thomas Douglas in Monash Bioethics Review
    Article Open access 12 December 2019
  6. Toward Control of Infectious Disease: Ethical Challenges for a Global Effort

    In this view from 2007–2009, the ethical challenges facing a potential global effort to control infectious disease are explored; they provide...
    Margaret P. Battin, Charles B. Smith, ... Jay A. Jacobson in International Public Health Policy and Ethics
    Chapter 2023
  7. Invisible epidemics: ethics and asymptomatic infection

    Interactions between microbes and human hosts can lead to a wide variety of possible outcomes including benefits to the host, asymptomatic infection,...

    Euzebiusz Jamrozik, Michael J. Selgelid in Monash Bioethics Review
    Article Open access 16 December 2020
  8. Layered vulnerability and researchers’ responsibilities: learning from research involving Kenyan adolescents living with perinatal HIV infection

    Background

    Carefully planned research is critical to develo** policies and interventions that counter physical, psychological and social challenges...

    Mary Kimani, Sassy Molyneux, ... Vicki Marsh in BMC Medical Ethics
    Article Open access 20 February 2024
  9. Optimal Control Strategies and Sensitivity Analysis of an HIV/AIDS-Resistant Model with Behavior Change

    Despite several research on HIV/AIDS, it is still incumbent to investigate more effective control measures to mitigate its infection level....

    Musa Rabiu, Robert Willie, Nabendra Parumasur in Acta Biotheoretica
    Article 30 July 2021
  10. Smart Control of Drinking Water Grids Using IoT

    Drinking water distribution systems facilitate carrying potable water from water resources such as lakes, rivers, and water tanks to industrial,...
    Chapter 2023
  11. Hospital Infection Prevention and Control (IPC) and Antimicrobial Stewardship (AMS): Dual Strategies to Reduce Antibiotic Resistance (ABR) in Hospitals

    In this chapter we review the development of hospital infection prevention and control (IPC) since the nineteenth century and its increasingly...
    Chapter Open access 2020
  12. Drug-Resistant Infection: Causes, Consequences, and Responses

    This chapter provides an overview of the causes and consequences of, and possible policy responses to, the problem of drug resistance. Throughout, we...
    Chapter Open access 2020
  13. Not in their hands only: hospital hygiene, evidence and collective moral responsibility

    Hospital acquired infections (HAIs) are a major threat to patient safety. This paper addresses the following question: given what is known about the...

    Saana Jukola, Mariacarla Gadebusch Bondio in Medicine, Health Care and Philosophy
    Article Open access 05 November 2022
  14. Ethics Education for Successful Infectious Disease Control of COVID-19

    The infection rates of COVID-19 have been exponential in some countries despite the imposition of infectious disease control measures such as...

    Hannah YeeFen Lim in Asian Bioethics Review
    Article Open access 22 May 2020
  15. Assessing the Effects of Holling Type-II Treatment Rate on HIV-TB Co-infection

    In this paper, a HIV-TB co-infection model is explored which incorporates a non-linear treatment rate for TB. We begin with presenting a HIV-TB...

    Tanvi, Rajiv Aggarwal, Tamas Kovacs in Acta Biotheoretica
    Article 16 June 2020
  16. Measuring Infection Transmission in a Stochastic SIV Model with Infection Reintroduction and Imperfect Vaccine

    An additional compartment of vaccinated individuals is considered in a SIS stochastic epidemic model with infection reintroduction. The...

    M. Gamboa, M. J. Lopez-Herrero in Acta Biotheoretica
    Article 08 January 2020
  17. Public perceptions on Controlled Human Infection Model (CHIM) studies—a qualitative pilot study from South India

    Research using Controlled Human Infection Models is yet to be attempted in India. This study was conducted to understand the perceptions of the lay...

    Manjulika Vaz, Olinda Timms, ... Mario Vaz in Monash Bioethics Review
    Article 21 October 2020
  18. A Biosocial Perspective on (COVID-19) Pandemic Outbreaks: Interfaces of Biology and Social Determinants

    This chapter deals on a theoretical level with the importance of interactions between biological and social factors in the epidemic or pandemic...
    Nico Dragano in Vulnerabilities
    Chapter 2023
  19. Justice in control of methicillin-resistant Staphylococcus aureus transmission: a fair question to ask?

    Active surveillance cultures and contact precautions is a strategy to control the transmission of methicillin-resistant Staphylococcus aureus (MRSA)...

    Teck Chuan Voo, Zohar Lederman in Monash Bioethics Review
    Article 13 April 2020
  20. Optimal Drug Regimen and Combined Drug Therapy and Its Efficacy in the Treatment of COVID-19: A Within-Host Modeling Study

    The COVID-19 pandemic has resulted in more than 524 million cases and 6 million deaths worldwide. Various drug interventions targeting multiple...

    Bishal Chhetri, Vijay M. Bhagat, ... Carani B. Sanjeevi in Acta Biotheoretica
    Article 19 May 2022
Did you find what you were looking for? Share feedback.